National Asthma Education and Prevention Program

Adapted from National Institutes of Health, National Heart Lung and Blood Institute. National Asthma Education and Prevention Program. 

NAEPP National Asthma Education and Prevention Program... 

The National Asthma Education and Prevention Program (NAEPP) defines asthma as a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role. In susceptible individuals, inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. These episodes are usually associated with airflow obstruction that is often reversible either spontaneously or with treatment. The inflammation also causes an increase in bronchial hyperresponsiveness (BHR) to a variety of stimuli. 

FIGURE 80-2. Home management of acute asthma exacerbation. Patients at risk of asthma-related death should receive immediate clinical attention after initial treatment. Additional therapy may be required. (MDI, metered-dose inhaler PEF, peak expiratory flow.) (Adapted from NHLBI, National Asthma Education and Prevention Program, Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051. Bethesda, MD U.S. Department of Health and Human Services, 1997.)... 

National Asthma Education and Prevention Program. (2002) Executive summary of the NAREPP expert panel report. Guidelines for the diagnosis and management of asthma. Update on selected topics 2002. Bethesda, MD National Institutes of Health. NIH publication 02-5075. 

Sympathomimetics Accor6 ng to the National Asthma Education and Prevention Program s Expert Panel Report II, long-acting 2-agonists (eg, salmeterol) are used... 

National Heart, Lung and Blood Institute (NHLBI). National Asthma Education and Prevention Program Program Description. NHLBI, NIH, 2002 1-5. Available at www.nhlbi.nih.gov/about/naepp/naep pd.htm. 

National Asthma Education and Prevention Program Expert Panel Report 2 Guidelines for the Diagnosis and Management of Asthma, National Heart, Lung, and Blood Institute Bethesda, Maryland, 1997, NIH Publication No. 97-4051. 

The National Asthma Education and Prevention Program recommends inhaled SAB As be used as needed for acute asthma exacerbation. The usual dose is 360 to 720 pg per four to eight puffs every 20 minutes up to 4 hours for albuterol metered-dose inhaler (MDI). This recommendation contrasts with previous ones for regular use of 180 pg per two puffs for albuterol MDI three to four times daily. Regular use of SABAs has been a standard approach without the scientific basis since 1970s [12]. Current guidelines indicate that inhaled LABAs (usual dose, 84 pg per two puffs for salmeterol MDI twice daily) should be combined with ICSs for asthma control, rather than used as a stand-alone therapy. 

National Asthma Education and Prevention Program Practical guide for the diagnosis and management of asthma. US Department of Health and Human Services, Public Health Service, NIH, NHLBI, NIH Publication 97-4055A, 1997. (NC)... 

Sullivan S, Elixhauser A, Buist AS, Luce BR, Eisenberg J, Weiss KB National Asthma Education and Prevention Program Working Group Report on the cost effectiveness of asthma care. Am J Respir Crit Care Med 1996 154(3 pt 2) S84-S95. 

Asthma has been known since antiquity, yet it is a disease that still defies precise definition. The word asthma is of Greek origin and means panting. More than 2000 years ago, Hippocrates used the word asthma to describe episodic shortness of breath however, the first detailed clinical description of the asthmatic patient was made by Are-taeus in the second century. An expert panel of the National Institutes of Health, the National Asthma Education and Prevention Program (NAEPP), has provided the following working definition of asthma ... 

---